Study title: A single-blind, multicentre, randomised, group comparative, 12- week post-marketing surveillance study demonstrate the safety of sodium cromoglycate 5 mg MDI versus INTAL 5 mg (5MG/10 mg q.i.d.) in 3600 adults, adolescent and paedriatric asthmatic patients - Domège N et al. - 31/05/2001
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: NEDOCROMIL | |||||
ATC code: S01GX04 | |||||
Document link: | |||||
Document date: | |||||
Study number: PNI1041-351 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |